More specifically, high BB-DNA levels could be considered a biomarker of diabetic nephropathy, as they have been associated with increased methylation levels of VEGFA and NMNAT1, key contributors to the progression of diabetic kidney disease. This evidence concerns the gene NMNAT1 and diabetic kidney disease.